0001144204-16-080888.txt : 20160211 0001144204-16-080888.hdr.sgml : 20160211 20160211162439 ACCESSION NUMBER: 0001144204-16-080888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160209 FILED AS OF DATE: 20160211 DATE AS OF CHANGE: 20160211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua BioMedical, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215-702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 FORMER COMPANY: FORMER CONFORMED NAME: Alliqua, Inc. DATE OF NAME CHANGE: 20101222 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pionati Pellegrino CENTRAL INDEX KEY: 0001645429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36278 FILM NUMBER: 161411822 MAIL ADDRESS: STREET 1: C/O ALLIQUA BIOMEDICAL, INC. STREET 2: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19041 4 1 v431335_4.xml OWNERSHIP DOCUMENT X0306 4 2016-02-09 0 0001054274 Alliqua BioMedical, Inc. ALQA 0001645429 Pionati Pellegrino C/O ALLIQUA BIOMEDICAL, INC. 2150 CABOT BOULEVARD WEST LANGHORNE PA 19041 0 1 0 0 See Remarks Common Stock 2016-02-09 4 A 0 14384 0 A 130896 D Represents a restricted stock award portion of Mr. Pionati's 2015 bonus amount based on the value of the Issuer's common stock on the date of grant. This award is subject to forfeiture until vested, with 100% vesting on February 9, 2017, subject to Mr. Pionati's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and Mr. Pionati, effective as of February 9, 2016. Chief Strategy and Marketing Officer /s/ Pellegrino Pionati 2016-02-11